Non GAAP gross profit for the 3 months ended September 30, 2023 was $900,000 as compared to $1,100,000 in the comparable period, which represents a gross profit margins of approximately 37% on a non GAAP basis for the 3 months ended September 30, 2023, as compared to 46 on a non GAAP basis in the comparable period. Revenue from teleradiology services for the 3 months End of September 30, 2023 was $2,200,000 with a gross profit of $200,000 on a GAAP basis As compared to revenue of $2,400,000 with a gross profit of $600,000 on a GAAP basis in the comparable period, which represents a gross profit margin of approximately 11% on a GAAP basis for the 3 months ended September 30, 2023, as compared to 26% on a GAAP basis in the comparable period. Non GAAP gross profit of the company's Cellular Radiology Cell Defense for the 3 months ended September 30, 2023 was $800,000 compared to $1,200,000 in the comparable period, which represents a gross profit margin of approximately 36% on a non GAAP basis for the 3 months ended September 30, 2023, as compared to 49% on a non GAAP basis in the comparable period. The decrease in the gross profit margins on a GAAP and non GAAP basis is mainly due to an increase in the cost of the company's radiologists Due to the decrease in the read rate and payments of incentive payments, which the company paid to the company's audiologists to engage in the reading During the 3 months ended September 30, 20 The company started to generate revenues through the sales and deployment of its imaging systems, which amounted to $99,000 with a gross profit of $36,000 on a GAAP and non GAAP basis, which represents a gross profit margins of approximately 37% on a GAAP and non GAAP basis.